Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Brian Abrahams Initiated (BCRX) at Hold and Held Target at $6 on, Sep 15th, 2017

Brian Abrahams of RBC Capital, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold and Held Target at $6 on, Sep 15th, 2017.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 0 agree with Brian's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Brian


  • Jessica Fye of "JP Morgan" Upgraded from Hold to Buy on, Wednesday, September 6th, 2017
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy on, Wednesday, September 6th, 2017